ACUTE LYMPHOBLASTIC LEUKAEMIA
Clinical trials for ACUTE LYMPHOBLASTIC LEUKAEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBLASTIC LEUKAEMIA trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBLASTIC LEUKAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill targets hard-to-treat leukemias in early trial
Disease control Recruiting nowThis study tests an experimental oral drug, AZD3632, in about 84 adults with advanced blood cancers (acute leukemias or high-risk MDS) that have certain genetic markers. The main goals are to check safety, find the right dose, and see if the drug shrinks the cancer. Participants …
Matched conditions: ACUTE LYMPHOBLASTIC LEUKAEMIA
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 04:33 UTC
-
New hope for tough blood cancers: experimental drug CC312 enters human testing
Disease control Recruiting nowThis early-stage study tests an experimental drug called CC312 in about 44 adults with certain blood cancers (like lymphoma or leukemia) that have returned or stopped responding to standard treatments. The main goals are to check the drug's safety and find the best dose. Research…
Matched conditions: ACUTE LYMPHOBLASTIC LEUKAEMIA
Phase: PHASE1 • Sponsor: CytoCares Inc • Aim: Disease control
Last updated May 18, 2026 12:11 UTC